Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Consolidated Net Income (2022 - 2023)

Historic Consolidated Net Income for Bluejay Diagnostics (BJDX) over the last 2 years, with Q2 2023 value amounting to -$2.9 million.

  • Bluejay Diagnostics' Consolidated Net Income fell 4622.81% to -$2.9 million in Q2 2023 from the same period last year, while for Dec 2023 it was -$5.6 million, marking a year-over-year increase of 4007.95%. This contributed to the annual value of -$7.8 million for FY2024, which is 2281.35% up from last year.
  • As of Q2 2023, Bluejay Diagnostics' Consolidated Net Income stood at -$2.9 million, which was down 4622.81% from -$2.7 million recorded in Q1 2023.
  • Bluejay Diagnostics' Consolidated Net Income's 5-year high stood at -$2.0 million during Q2 2022, with a 5-year trough of -$2.9 million in Q2 2023.